{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:01:09Z","timestamp":1761919269119},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T00:00:00Z","timestamp":1253750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>A mildly increased serum thyrotrophin (TSH) is usually because of mild thyroid failure, and the most common aetiology in iodine\u2010replete communities is chronic autoimmune thyroiditis. It is more common in women, and the prevalence increases with age in both men and women and is associated with the presence of antithyroid antibodies. The majority will have serum TSH levels between 5\u201310\u2003mIU\/l, normal free thyroxine (T4) levels and relatively few symptoms. In 2004, US evidence\u2010based consensus guidelines concluded that there were no adverse outcomes of a mildly increased serum TSH other than a risk of progression to overt hypothyroidism and few data to justify levothyroxine therapy. There is still debate as to what constitutes an increased serum TSH, particularly in older subjects. Although some subjects will progress to overt hypothyroidism, recent data suggest a significant proportion revert to a serum TSH within the reference range without treatment. Two recent meta\u2010analyses have suggested that the possible cardiovascular risks may be more significant in younger adults. Other data suggest that mild thyroid failure may be the only reversible cause of left ventricular diastolic dysfunction. No appropriately powered prospective, randomized, controlled, double\u2010blinded interventional trial of levothyroxine therapy for a mildly increased serum TSH exists. However, treatment in subjects who are symptomatic, pregnant or preconception, aged less than 65\u2003years and older subjects with evidence of heart failure appear justified.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2009.03720.x","type":"journal-article","created":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T15:32:36Z","timestamp":1253806356000},"page":"436-440","source":"Crossref","is-referenced-by-count":11,"title":["How should we manage patients with mildly increased serum thyrotrophin concentrations?"],"prefix":"10.1111","volume":"72","author":[{"given":"Mark P. J.","family":"Vanderpump","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,3]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15696-1"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2006-0043"},{"key":"e_1_2_10_4_2","volume-title":"UK Guidelines for the Use of Thyroid Function Tests","author":"Association of Clinical Biochemistry, British Thyroid Association and British Thyroid Foundation","year":"2006"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/105072502761016458"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1977.tb01340.x"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.4.526"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8182"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb01739.x"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1557"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1499"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.2.228"},{"key":"e_1_2_10_13_2","first-page":"CD003419","article-title":"Thyroid hormone replacement for subclinical hypothyroidism","volume":"3","author":"Villar H.C.","year":"2007","journal-title":"Cochrane Database Systems Review"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a801"},{"key":"e_1_2_10_15_2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/thy.2008.0239","article-title":"Clinical evolution of autoimmune thyroiditis in children and adolescents","volume":"19","author":"Fava A.","year":"2009","journal-title":"Thyroid"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0375"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0625"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1500751"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0141"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1775"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2008.11.002"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.14.1533"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb01894.x"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.15.1657"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-11-200806030-00225"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0167"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.21.2591"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2325"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.07.009"},{"key":"e_1_2_10_30_2","first-page":"107","article-title":"Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment","volume":"43","author":"Parle J.V.","year":"1993","journal-title":"British Journal of General Practice"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2009.03720.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2009.03720.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:39:50Z","timestamp":1697427590000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2009.03720.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,3]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1365-2265.2009.03720.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03720.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,3]]}}}